Moderna’s Shift to Cancer Company Lifts Stock Up 177%

NYT Science•Thu, Aug 20, 2026, 09:04 AM•2 min read

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.

Source: [NYT Science](https://www.nytimes.com/2026/08/20/business/moderna-cancer-melanoma.html)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at NYT Science ↗

#health #company #moderna #shift #cancer #lifts #stock #fortunes #cratered

More Headlines

FinanceInvesting.com• 20m ago

Rain enhancement technologies CEO Randy Seidl buys $104k stock

Developing story — details emerging. Check the source link for the latest updates.

HealthBBC News• 1h ago

Wellness habits you can start now - at no (or little) cost

Living a healthy life doesn't have to just be about pricey studio classes and luxury retreats.

HealthPhys.org• 1h ago

Occupational health challenges require more than individual support, new doctoral study shows

Mental health issues are now the most prevalent cause of sick leave in Finland. It is common for an employee's declining occupational well-being to result in a sick leave referral, while nothing changes at the workplace itself.

HealthCBS News• 2h ago

Medical nightmare in Tennessee hospital after drug mix-up

A dangerous drug mix-up at a Tennessee hospital left several patients badly injured this week. Nicole Valdes reports.

FinanceInvesting.com• 2h ago

5am Partners VII, LLC sells $140,313 of Skye Bioscience stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 2h ago

10% owner DST Global Advisors sells $156.9m in Chime Financial stock

Developing story — details emerging. Check the source link for the latest updates.